Recent initiatives in the Republic of Srpska to enhance appropriate use of antibiotics in ambulatory care: their influence and implications

Ljubica Bojanić, Vanda Marković-Peković, Ranko Škrbić, Nataša Stojaković, Mirjana Đermanović, Janja Bojanić, Jurij Fürst, Amanj B. Kurdi, Brian Godman

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Introduction:There are increasing concerns world-wide with growing rates of antibiotic resistance necessitating urgent action. There have been a number of initiatives in the Republic of Srpska in recent years to address this and improve rational antibiotic prescribing and dispensing despite limited resources to fund multiple initiatives. Objective: Analyse antibiotic utilization patterns in the Republic of Srpska following these multiple initiatives as a basis for developing future programmes in the Republic if needed. Methods: Observational retrospective study of total outpatient antibiotic utilization from 2010 to 2015, based on data obtained from the Public Health Institute, alongside documentation of ongoing initiatives to influence utilization. The quality of antibiotic utilisation principally assessed according to ESAC, ECDC and WHO quality indicators and DU 90% (the drug utilization 90%) profile as well as versus neighbouring countries. Results: Following multiple initiatives, antibiotic utilization remained relatively stable in the Republic at 15.6 DIDs to 18.4 DIDs, with a decreasing trend in recent years, with rates comparable or lower than neighbouring countries. Amoxicillin and the penicillins accounted for 29%-40% and 50% of total utilization, respectively. Overall, limited utilization of co-amoxiclav (7% - 11%), cephalosporins, macrolides and quinolones, as well as low use of third and fourth generation cephalosporins versus first and second cephalosporins. However, increasing utilization of co-amoxiclav and azithromycin, as well as higher rates of quinolone utilization compared to some countries, was seen. Conclusions: Multiple interventions in the Republic of Srpska in recent years have resulted in one of the lowest utilisation of antibiotics when compared with similar countries, acting as an exemplar to others. However, there are some concerns with current utilisation of co-amoxiclav and azithromycin which are being addressed. This will be the subject of future research activities.
LanguageEnglish
Article number442
Number of pages13
JournalFrontiers in Pharmacology
Volume9
Early online date16 Apr 2018
DOIs
Publication statusPublished - 29 May 2018

Fingerprint

Ambulatory Care
Anti-Bacterial Agents
Amoxicillin-Potassium Clavulanate Combination
Cephalosporins
Azithromycin
Quinolones
Drug Utilization
Amoxicillin
Macrolides
Financial Management
Microbial Drug Resistance
Penicillins
Documentation
Observational Studies
Outpatients
Retrospective Studies
Public Health
Research

Keywords

  • antibiotic resistance
  • antimicrobial resistance
  • ambulatory care

Cite this

Bojanić, Ljubica ; Marković-Peković, Vanda ; Škrbić, Ranko ; Stojaković, Nataša ; Đermanović, Mirjana ; Bojanić, Janja ; Fürst, Jurij ; Kurdi, Amanj B. ; Godman, Brian. / Recent initiatives in the Republic of Srpska to enhance appropriate use of antibiotics in ambulatory care : their influence and implications. In: Frontiers in Pharmacology . 2018 ; Vol. 9.
@article{4c5668ecd45a4bfcbba2f357122975f2,
title = "Recent initiatives in the Republic of Srpska to enhance appropriate use of antibiotics in ambulatory care: their influence and implications",
abstract = "Introduction:There are increasing concerns world-wide with growing rates of antibiotic resistance necessitating urgent action. There have been a number of initiatives in the Republic of Srpska in recent years to address this and improve rational antibiotic prescribing and dispensing despite limited resources to fund multiple initiatives. Objective: Analyse antibiotic utilization patterns in the Republic of Srpska following these multiple initiatives as a basis for developing future programmes in the Republic if needed. Methods: Observational retrospective study of total outpatient antibiotic utilization from 2010 to 2015, based on data obtained from the Public Health Institute, alongside documentation of ongoing initiatives to influence utilization. The quality of antibiotic utilisation principally assessed according to ESAC, ECDC and WHO quality indicators and DU 90{\%} (the drug utilization 90{\%}) profile as well as versus neighbouring countries. Results: Following multiple initiatives, antibiotic utilization remained relatively stable in the Republic at 15.6 DIDs to 18.4 DIDs, with a decreasing trend in recent years, with rates comparable or lower than neighbouring countries. Amoxicillin and the penicillins accounted for 29{\%}-40{\%} and 50{\%} of total utilization, respectively. Overall, limited utilization of co-amoxiclav (7{\%} - 11{\%}), cephalosporins, macrolides and quinolones, as well as low use of third and fourth generation cephalosporins versus first and second cephalosporins. However, increasing utilization of co-amoxiclav and azithromycin, as well as higher rates of quinolone utilization compared to some countries, was seen. Conclusions: Multiple interventions in the Republic of Srpska in recent years have resulted in one of the lowest utilisation of antibiotics when compared with similar countries, acting as an exemplar to others. However, there are some concerns with current utilisation of co-amoxiclav and azithromycin which are being addressed. This will be the subject of future research activities.",
keywords = "antibiotic resistance, antimicrobial resistance, ambulatory care",
author = "Ljubica Bojanić and Vanda Marković-Peković and Ranko Škrbić and Nataša Stojaković and Mirjana Đermanović and Janja Bojanić and Jurij F{\"u}rst and Kurdi, {Amanj B.} and Brian Godman",
year = "2018",
month = "5",
day = "29",
doi = "10.3389/fphar.2018.00442",
language = "English",
volume = "9",
journal = "Frontiers in Pharmacology",
issn = "1663-9812",

}

Recent initiatives in the Republic of Srpska to enhance appropriate use of antibiotics in ambulatory care : their influence and implications. / Bojanić, Ljubica; Marković-Peković, Vanda; Škrbić, Ranko; Stojaković, Nataša ; Đermanović, Mirjana; Bojanić, Janja; Fürst, Jurij; Kurdi, Amanj B.; Godman, Brian.

In: Frontiers in Pharmacology , Vol. 9, 442, 29.05.2018.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Recent initiatives in the Republic of Srpska to enhance appropriate use of antibiotics in ambulatory care

T2 - Frontiers in Pharmacology

AU - Bojanić, Ljubica

AU - Marković-Peković, Vanda

AU - Škrbić, Ranko

AU - Stojaković, Nataša

AU - Đermanović, Mirjana

AU - Bojanić, Janja

AU - Fürst, Jurij

AU - Kurdi, Amanj B.

AU - Godman, Brian

PY - 2018/5/29

Y1 - 2018/5/29

N2 - Introduction:There are increasing concerns world-wide with growing rates of antibiotic resistance necessitating urgent action. There have been a number of initiatives in the Republic of Srpska in recent years to address this and improve rational antibiotic prescribing and dispensing despite limited resources to fund multiple initiatives. Objective: Analyse antibiotic utilization patterns in the Republic of Srpska following these multiple initiatives as a basis for developing future programmes in the Republic if needed. Methods: Observational retrospective study of total outpatient antibiotic utilization from 2010 to 2015, based on data obtained from the Public Health Institute, alongside documentation of ongoing initiatives to influence utilization. The quality of antibiotic utilisation principally assessed according to ESAC, ECDC and WHO quality indicators and DU 90% (the drug utilization 90%) profile as well as versus neighbouring countries. Results: Following multiple initiatives, antibiotic utilization remained relatively stable in the Republic at 15.6 DIDs to 18.4 DIDs, with a decreasing trend in recent years, with rates comparable or lower than neighbouring countries. Amoxicillin and the penicillins accounted for 29%-40% and 50% of total utilization, respectively. Overall, limited utilization of co-amoxiclav (7% - 11%), cephalosporins, macrolides and quinolones, as well as low use of third and fourth generation cephalosporins versus first and second cephalosporins. However, increasing utilization of co-amoxiclav and azithromycin, as well as higher rates of quinolone utilization compared to some countries, was seen. Conclusions: Multiple interventions in the Republic of Srpska in recent years have resulted in one of the lowest utilisation of antibiotics when compared with similar countries, acting as an exemplar to others. However, there are some concerns with current utilisation of co-amoxiclav and azithromycin which are being addressed. This will be the subject of future research activities.

AB - Introduction:There are increasing concerns world-wide with growing rates of antibiotic resistance necessitating urgent action. There have been a number of initiatives in the Republic of Srpska in recent years to address this and improve rational antibiotic prescribing and dispensing despite limited resources to fund multiple initiatives. Objective: Analyse antibiotic utilization patterns in the Republic of Srpska following these multiple initiatives as a basis for developing future programmes in the Republic if needed. Methods: Observational retrospective study of total outpatient antibiotic utilization from 2010 to 2015, based on data obtained from the Public Health Institute, alongside documentation of ongoing initiatives to influence utilization. The quality of antibiotic utilisation principally assessed according to ESAC, ECDC and WHO quality indicators and DU 90% (the drug utilization 90%) profile as well as versus neighbouring countries. Results: Following multiple initiatives, antibiotic utilization remained relatively stable in the Republic at 15.6 DIDs to 18.4 DIDs, with a decreasing trend in recent years, with rates comparable or lower than neighbouring countries. Amoxicillin and the penicillins accounted for 29%-40% and 50% of total utilization, respectively. Overall, limited utilization of co-amoxiclav (7% - 11%), cephalosporins, macrolides and quinolones, as well as low use of third and fourth generation cephalosporins versus first and second cephalosporins. However, increasing utilization of co-amoxiclav and azithromycin, as well as higher rates of quinolone utilization compared to some countries, was seen. Conclusions: Multiple interventions in the Republic of Srpska in recent years have resulted in one of the lowest utilisation of antibiotics when compared with similar countries, acting as an exemplar to others. However, there are some concerns with current utilisation of co-amoxiclav and azithromycin which are being addressed. This will be the subject of future research activities.

KW - antibiotic resistance

KW - antimicrobial resistance

KW - ambulatory care

UR - https://www.frontiersin.org/articles/10.3389/fphar.2018.00442/abstract

U2 - 10.3389/fphar.2018.00442

DO - 10.3389/fphar.2018.00442

M3 - Article

VL - 9

JO - Frontiers in Pharmacology

JF - Frontiers in Pharmacology

SN - 1663-9812

M1 - 442

ER -